Skip to content

Novel three dimensional echocardiographic guided optimization improves clinical outcome in cardiac resynchronization therapy compared to electrocardiographic optimization - results of a randomized comparison

Novel three dimensional echocardiographic guided optimization improves clinical outcome in cardiac resynchronization therapy compared to electrocardiographic optimization - results of a randomized comparison

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004454
Enrollment
77
Registered
2012-10-09
Start date
2010-01-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I50.9

Interventions

Group 1: echocardiographic optimization of cardiac resynchronization therapy Group 2: electrocardiographic optimization of cardiac resynchronization therapy

Sponsors

Deutsches Herzzentrum München, TU München
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with planned CRT implantation, EF 120 ms

Exclusion criteria

Exclusion criteria: persistent atrial tachyarrhythmias, symptomatic bradycardias, relevant valvular disease, instable coronary artery disease, coronary intervention three months before study enrollment, significant comorbidities like chronic obstructive lung disease with chronic oxygen requirement

Design outcomes

Primary

MeasureTime frame
Response to CRT was defined as a reduction of NYHA class by =1 score. The primary endpoint of the study was a comparison of this clinical response between group 1 and 2. NYHA-class was evaluated at the beginning of the study during the hospital stay before cardiac resynchronization therapy and at 3 months follow up in the hospital clinic with a patient history and documented in the patients records.

Secondary

MeasureTime frame
The secondary endpoints were an echocardiographic comparison of improvement of EF, as well as a decrease of EDV, ESV and SDI between the two groups. Echocardiography (3-dimensional) was conducted at the beginning of the study during the hospital stay before cardiac resynchronization therapy and at 3 months follow up in the hospital clinic.

Countries

Germany

Contacts

Public ContactCarolin Sonne

Deutsches Herzzentrum München

carolin.sonne@lrz.tum.de089/1218-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026